G 2 /M cell cycle arrest on HT-29 cancer cells and toxicity assessment of triphenylphosphanegold(I) carbonimidothioates, Ph 3 PAu[SC(OR) = NPh], R = Me, Et, and iPr, during zebrafish development
- 1 January 2017
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 166, 173-181
Abstract
No abstract availableKeywords
Funding Information
- Sunway University
- Ministry of Higher Education (UM.C/HIR-MOHE/SC/12)
This publication has 48 references indexed in Scilit:
- Chemical biology of anticancer gold( iii ) and gold( i ) complexesChemical Society Reviews, 2015
- A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compoundsDalton Transactions, 2013
- Gold compounds as therapeutic agents for human diseasesMetallomics, 2011
- The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapyMolecular Aspects of Medicine, 2010
- On the medicinal chemistry of gold complexes as anticancer drugsCoordination Chemistry Reviews, 2009
- Targeting the mitochondrial cell death pathway with gold compoundsCoordination Chemistry Reviews, 2007
- The Pathophysiology of Mitochondrial Cell DeathScience, 2004
- Gold derivatives for the treatment of cancerCritical Reviews in Oncology/Hematology, 2002
- Gold-Based Therapeutic AgentsChemical Reviews, 1999
- Phosphines and metal phosphine complexes: Relationship of chemistry to anticancer and other biological activity1988